PLLWF (Polarean Imaging) Common Stock : $0.57 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging Common Stock?

Polarean Imaging's quarterly common stock increased from Jun. 2023 ($0.10 Mil) to Dec. 2023 ($0.11 Mil) and increased from Dec. 2023 ($0.11 Mil) to Jun. 2024 ($0.57 Mil).

Polarean Imaging's annual common stock increased from Dec. 2021 ($0.10 Mil) to Dec. 2022 ($0.10 Mil) and increased from Dec. 2022 ($0.10 Mil) to Dec. 2023 ($0.11 Mil).

Polarean Imaging Common Stock Historical Data

The historical data trend for Polarean Imaging's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging Common Stock Chart

Polarean Imaging Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.06

0.08

0.10

0.11

Polarean Imaging Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Common Stock	Get a 7-Day Free Trial										0.10	0.10	0.10	0.11	0.57

Polarean Imaging Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Polarean Imaging Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (OTCPK:PLLWF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

POLX:UK

Address

27-28 Eastcastle Street, London, GBR, W1W 8DH

Website

https://www.polarean.com

Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives majority of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging Headlines

From GuruFocus

Polarean Imaging Plc ("Polarean" or the "Company") NDA Submission

By Business Wire Business Wire • 10-07-2020

Polarean Scientific Presentations on Hyperpolarized 129Xenon at Upcoming Medical Meetings

By Business Wire Business Wire • 07-30-2020